⚖️ Weight Loss

Weight Loss Health Findings

Research-backed health and safety findings about everyday weight loss products.

Findings

Products

Ozempic and similar weight-loss drugs linked to foot problems, doctors warn

Doctors are warning that Ozempic and similar weight-loss drugs can cause foot problems, a side effect many patients don't expect. The condition, nicknamed "Ozempic feet," appears to develop as people lose weight rapidly on these medications. If you're taking a GLP-1 drug for weight loss, it's worth watching for foot pain or skin changes and discussing them with your doctor.

Medium Concern

📰 News reportGoogle Health News

7Jul 12, 2026

People who lost the most weight on Ozempic saw huge health b⚖️ Weight Loss🔥 Trending

Significant weight loss on Ozempic linked to lower risks of obesity-related diseases

People who lost the most weight on Ozempic, Wegovy, Mounjaro, or Saxenda saw major drops in their risk of obesity-related conditions like sleep apnea and kidney disease. Those who gained weight instead faced higher risks, especially for heart failure, even when they stopped taking the drugs within a year. The findings show how much the amount of weight lost matters for your health outcomes on these medications.

Medium Concern

🔬 Peer-reviewedScience Daily – Health

26May 21, 2026

Tirzepatide for maintenance of bodyweight reducti⚖️ Weight Loss

Tirzepatide maintains weight loss in adults with obesity, study finds

Adults who stop taking tirzepatide after weight loss tend to regain the weight, but continuing the drug keeps the weight off and protects heart health. A lower dose of 5 mg might work for some people who can't tolerate higher doses, though results vary by individual. This shows that obesity treatment needs to be ongoing, not just short-term.

Medium Concern

🔬 Peer-reviewedThe Lancet

15May 19, 2026

Popular Weight-Loss Drugs⚖️ Weight Loss

Weight-loss drugs linked to lower heart attack and stroke risk

GLP-1 weight-loss drugs, commonly used to treat diabetes and obesity, can lower your risk of heart attack, stroke, and irregular heartbeat. This matters because these drugs offer heart protection beyond just helping people lose weight. Researchers found these cardiovascular benefits across multiple studies of different GLP-1 medications.

Medium Concern

📰 News reportGoogle Health News

23May 4, 2026

Bariatric surgery⚖️ Weight Loss

Bariatric surgery reduces heart disease risk more than weight-loss medications

People with obesity who have bariatric surgery see greater long-term reductions in heart disease risk compared to those taking GLP-1 weight-loss medications, according to a new study. Both treatments improve heart health, but surgery delivered stronger protection against future cardiovascular problems. If you're considering obesity treatment options, these findings can help you weigh the long-term heart benefits of each approach.

Medium Concern

📰 News reportMedical Xpress – Health

23Apr 30, 2026

[Articles] Efficacy and safety of oral semaglutide 14 mg (fl⚖️ Weight Loss

Oral semaglutide fails to slow early Alzheimer's disease progression

Oral semaglutide did not slow the progression of early-stage Alzheimer's disease in clinical trials. The drug was well-tolerated, but failed to show benefits for this condition. This finding matters because semaglutide is widely used for weight loss and diabetes, and researchers had hoped it might help prevent cognitive decline.

Medium Concern

🔬 Peer-reviewedThe Lancet

11Apr 27, 2026

GLP-1 Drugs⚖️ Weight Loss

GLP-1 drugs linked to cognitive impairment in new study

People taking GLP-1 drugs for weight loss or diabetes may experience cognitive problems, though not always from the drug itself. Researchers found that rapid weight loss from these medications can sometimes trigger brain issues if it happens too quickly. Talk to your doctor about the right pace for weight loss if you're considering these drugs.

Medium Concern

📰 News reportGoogle Health News

13Apr 26, 2026

Along with rapid weight loss, patients see other benefits an⚖️ Weight Loss

GLP-1 drugs linked to rapid weight loss, benefits and risks

GLP-1 weight-loss drugs help people shed pounds quickly, but they also come with side effects and risks that users need to understand. Patients taking these medications often make mistakes in how they use them, which can reduce benefits or cause harm. It's important to weigh the real advantages against potential downsides before starting treatment.

Medium Concern

📰 News reportGoogle Health News

10Apr 26, 2026

Patients taking weight-loss drugs often make 5 critical mist⚖️ Weight Loss

Patients taking weight-loss drugs often make 5 critical mistakes

People taking popular weight-loss drugs like Ozempic and Wegovy often use them incorrectly in ways that reduce their effectiveness or raise health risks. A doctor identified five common mistakes, including stopping the medication too soon and not combining it with diet and exercise changes. Understanding how to use these drugs properly matters because they're increasingly prescribed and misuse can lead to weight regain or other health problems.

Medium Concern

📰 News reportGoogle Health News

11Apr 26, 2026

Simple ‘metabolic reset’⚖️ Weight Loss

Metabolic reset may prevent weight rebound after stopping GLP-1 drugs

People who stop taking GLP-1 drugs like Ozempic often regain weight, but a new metabolic reset approach can help prevent that rebound. The strategy involves specific diet and exercise changes that keep your body from returning to old eating patterns. This matters because many people can't stay on these drugs long-term due to cost or side effects.

Medium Concern

📰 News reportGoogle Health News

10Apr 26, 2026

Browse other categories

🍎 Food(49)🥤 Beverages(8)🏠 Household(2)💄 Beauty(1)🧴 Personal Care(1)💊 Supplements(10)🧸 Children's Products(7)🦷 Dental(1)💉 Medication & Drugs(8)🧠 Mental Health(9)📱 Electronics(2)🌱 Environment

Weight Loss Health Findings

Ozempic and similar weight-loss drugs linked to foot problems, doctors warn

Significant weight loss on Ozempic linked to lower risks of obesity-related diseases

Tirzepatide maintains weight loss in adults with obesity, study finds

Weight-loss drugs linked to lower heart attack and stroke risk

Bariatric surgery reduces heart disease risk more than weight-loss medications

Oral semaglutide fails to slow early Alzheimer's disease progression

GLP-1 drugs linked to cognitive impairment in new study

GLP-1 drugs linked to rapid weight loss, benefits and risks

Patients taking weight-loss drugs often make 5 critical mistakes

Metabolic reset may prevent weight rebound after stopping GLP-1 drugs

Browse other categories

Never miss a finding